EVENT DETAILS
Wednesday, April 11, 2018
Crowne Plaza Hotel
801 Greenwich Avenue
Warwick, RI 02886
Time
8:00 AM - 5:00 PM
Total Credits
7 Contact Hour(s)
Target Audience
Pharmacist , Pharmacy Technician
Cost
$129.00
Registration closes on 4/10/2018 at 11:00 PM
 

Registration will be held from 8:00 am - 8:30 am. Continental breakfast will be served during this time.

A plated lunch will be served from 12:00 pm - 1:00 pm.

Refreshments will be served during the afternoon programs.

 

AGENDA

Scheduled CE Activities Wednesday, April 11, 2018
  
The current overdose epidemic has impacted Rhode Island more than most states. Rhode Island has been a leader nationwide in developing and implementing novel and effective approaches to reducing overdose deaths. This epidemic continues to be challenging and dynamic. This continuing education program for pharmacists and pharmacy technicians will review the causes of this epidemic, the nature of the underlying disease, and provide an update on where the epidemic is and what current approaches are available.
 
 
Pharmacist Learning Objectives
  • Describe the scope and epidemiology of the nationwide opioid pandemic.
  • Recognize the disease of addiction and the roots of our current opioid epidemic
  • Discuss the efficacy of available medications used to treat opioid addiction and overdose.
  • Explain the role of pharmacists in overdose prevention and providing resources to help individuals and caregivers find qualified treatment and recovery resources.
Pharmacy Technician Learning Objectives
  • Describe the scope and epidemiology of the nationwide opioid pandemic.
  • Recognize the disease of addiction and the roots of our current opioid epidemic
  • Discuss the efficacy of available medications used to treat opioid addiction and overdose.
 
Faculty
Josiah RichMD, MPH
Attending Physician, Infectious Disease Specialist, Director of "The Center for Prisoner Health and Human Rights" - The Miriam Hospital and Professor of Medicine and Epidemiology - Brown University
 
ACPE UAN
0280-9999-18-011-L01-P (Knowledge-Based)
0280-9999-18-011-L01-T (Knowledge-Based)
 
Credits
1.5
 
Handouts
 
Depression impacts an estimated 6.7% of the U.S. population, making it the most common mental disorder in the United States, with many cases being undiagnosed and/or untreated. Tragically, a diagnosis of depression increases an individual's risk for suicide by almost twenty-fold. Suicide, however, is a completely preventable phenomenon. Statistically, pharmacists and pharmacy technicians find themselves staring at the perilous front line of this battle on a continuous basis. The very front line of the battle, however, often goes unrecognized and unaddressed.

This session seeks to review the functionality of major classes of antidepressant medications, highlighting the most common prescribing concerns among the various classes. Additionally, the session seeks to evaluate the pharmacist and pharmacy technician's role in recognizing suicidal behaviors and appropriate follow up actions. 

 
 
Pharmacist Learning Objectives
  • Identify the symptoms and characteristics of depression.
  • Critically evaluate the relationship between depression, antidepressant medications, and suicide risk.
  • Identify appropriate professional discussion and interventions in communicating with patients at an increase risk for suicide.
Pharmacy Technician Learning Objectives
  • Identify the symptoms and characteristics of depression.
  • Critically evaluate the relationship between depression, antidepressant medications, and suicide risk.
  • Identify appropriate professional discussion and interventions in communicating with patients at an increase risk for suicide.
 
Faculty
Kevin HopeRPh
Clinical Education Specialist and Continuing Education Administrator, PharmCon, Inc.; Advisory Board Member, Paradigm Education Solutions; Nuclear Pharmacist, Triad Isotopes
 
ACPE UAN
0280-0000-18-008-L01-P (Knowledge-Based)
0280-0000-18-008-L01-T (Knowledge-Based)
 
Credits
1.5
 
Handouts
 
Diabetes mellitus is a metabolic disorder characterized by persistent hyperglycemia. Diabetes related complications directly correlate with levels of glycemic control, thus earlier outcome studies focused on the attainment of tight glycemic control as well as optimization of cardiovascular risk factors. Despite optimal glycemic control and control of cardiovascular disease risk factors residual cardiovascular risk of unclear etiology remained. Therefore, in 2008 the Food and Drug Administration introduced a guidance for industry that requires the investigation of cardiovascular outcomes of glucose-lowering medications. Since then, an increasing number of cardiovascular outcome trials (CVOTs) have been completed in patients with diabetes who are at increased cardiovascular risk. This continuing education program for pharmacist and pharmacy technicians will summarize the CVOTs for long-acting insulin agents, GLP-1 receptor agonists, DPP-4 inhibitors, and SGLT-2 antagonists.
 
 
Pharmacist Learning Objectives
  • Identify key updates in the 2018 American Diabetes Association Standards of Care for the glycemic management of type 2 diabetes mellitus.
  • Describe the results of key findings from prospective cardiovascular outcome trials (CVOTs) for glycemic agents for type 2 diabetes.
  • Select a glucose-lowering medication regimen for patients with, or at high risk for, cardiovascular disease.
Pharmacy Technician Learning Objectives
  • Recognize the hierarchy of glucose lowering agents within current national treatment guidelines.
  • Discuss the MOA and potential adverse effects associated with the use of glucose-lowering medications.
 
Faculty
Tracey TaveiraPharmD, CDOE, CVDOE
Professor of Pharmacy, University of Rhode Island College of Pharmacy Adjunct Professor of Medicine, Warren Alpert School of Medicine, Brown University Providence VA Medical Center
 
ACPE UAN
0280-0000-18-009-L01-P (Knowledge-Based)
0280-0000-18-009-L01-T (Knowledge-Based)
 
Credits
2
 
Handouts
 
A presentation on current pharmacy laws and regulations up to 2018 will be provided with emphasis on Rhode Island laws. Attendees will also be updated on new laws/regulations for MA and CT. This program explains new laws/regulations and how they affect pharmacy practice.
 
 
Pharmacist Learning Objectives
  • List the new laws and describe how they apply in your practice.
  • Review the basics of lab tests that pharmacists can perform.
  • Explain the biosimilars and the regulation around dispensing.
  • Recognize different laws and regulations in neighboring states.
Pharmacy Technician Learning Objectives
  • Discuss the abuse potential of schedule V cough syrups.
  • Review the pharmacy technician's role assisting pharmacists in scrutinizing fraudulent prescriptions.
  • Identify how a prescription should be written correctly for opioids in patients with acute pain based on the new prescribing laws.
  • Clarify which components can be changed on a schedule II prescription by calling the prescriber.
  • Explain the substitution of biological products.
 
Faculty
Peter RagostaRPh, CSCI
Chief Administrative Officer, Rhode Island Board of Pharmacy
 
ACPE UAN
0280-0000-18-010-L03-P (Knowledge-Based)
0280-0000-18-010-L03-T (Knowledge-Based)
 
Credits
2
 
Handouts
 
 
 
 
Requirements for CE Credit
  • Participant Requirement and Statement of Credit: To receive credit, participants must fully attend each session (no partial credit will be awarded), pass in a completed attendance verification form, and using the access code provided, complete the online evaluation for each session attended. Attendance will be verified. All participants will have the opportunity to evaluate the educational sessions and presenters as well as the ability to identify their
  • Pharmacists and Pharmacy Technicians: CE credit will be automatically uploaded to CPE Monitor upon completion of the evaluation and posted to the participant’s NABP account within 72 hours where an official certificate of credit can be printed. Evaluations must be completed within 60 days of program date to receive credit.
  • Statement of Disclosure: Disclosure will be made on the day of the program regarding any interest or affiliation a speaker may have with a supporting organization.
  • Refund Policy: A full refund will be provided only if a written request is received by American Health Resources, LLC at least 48 hours prior to the program or if the program is cancelled. American Health Resources, LLC reserves the right to change the presenters, topics or seminar schedules.
 
Only Certificates of Credit issued from CPE Monitor are valid in the US.
CPE Monitor will not accept credits after 60 days from the session date.
 
Registration closes on 4/10/2018 at 11:00 PM
 

CONTINUING EDUCATION

843 488 5550 Office

843 488 5554 Fax

info@ahrevents.com Email

www.ahrevents.com Web

341 Wellness Drive, Myrtle Beach, SC 29579 Address

©2015 PharmCon, lnc. All Rights Reserved | Terms & Conditions | Privacy PolicyAmerican Health Resources, LLC a subsidiary of PharmCon, Inc.
Developed By: ITB, Inc.